diosgenin has been researched along with Malignant Melanoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Long, J; Pi, X | 1 |
Huang, W; Li, L; Li, S; Li, Y; Ming, Y; Niu, H; Wang, H; Wei, Z; Xin, G; Xing, Z; Zeng, Z; Zhang, B; Zhang, J; Zhang, X | 1 |
Chen, G; Xie, Y | 1 |
Beneytout, JL; Corbiere, C; Liagre, B; Terro, F | 1 |
Chai, H; Cordell, GA; Farnsworth, NR; Hollingshead, MG; Kardono, LB; Kinghorn, AD; Lantvit, D; Lee, IS; Mayo, JG; Mi, Q; Ngassapa, O; Peraza-Sánchez, S; Pezzuto, JM; Reyes-Lim, E; Riswan, S; Zhao, W | 1 |
5 other study(ies) available for diosgenin and Malignant Melanoma
Article | Year |
---|---|
Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway.
Topics: Animals; Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Diosgenin; Humans; Male; Melanoma; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Diosgenin; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Male; Melanoma; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice, Inbred BALB C; Nanoparticles; Prodrugs; Skin Neoplasms; Tissue Distribution | 2020 |
Dioscin induces ferroptosis and synergistic cytotoxicity with chemotherapeutics in melanoma cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzophenanthridines; Cation Transport Proteins; Cell Death; Cell Line, Tumor; Cell Survival; Cyclohexylamines; Diosgenin; Drug Synergism; Ferroptosis; Humans; Iron; Malondialdehyde; Melanoma; Phenylenediamines; Reactive Oxygen Species; RNA, Small Interfering; Transferrin | 2021 |
Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells.
Topics: Apoptosis Inducing Factor; bcl-2-Associated X Protein; Caspase 3; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Diosgenin; DNA Fragmentation; Flavoproteins; Humans; Intracellular Membranes; Laryngeal Neoplasms; Melanoma; Membrane Proteins; Mitochondria; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2004 |
Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests.
Topics: Animals; Biological Factors; Colonic Neoplasms; Diosgenin; Disease Models, Animal; Diterpenes; Drug Screening Assays, Antitumor; Female; Heterocyclic Compounds, 3-Ring; HL-60 Cells; Humans; Inhibitory Concentration 50; KB Cells; Leukemia P388; Male; Melanoma; Mice; Molecular Structure; Naphthoquinones; Ovarian Neoplasms; Paclitaxel; Polymers; Prostatic Neoplasms; Triterpenes; Tumor Cells, Cultured | 2002 |